This community webinar, hosted by FAST and the Angelman Syndrome Association (ASA), features representatives from Ionis and Ultragenyx discussing Phase 3 clinical trials in Europe and the UK.
Topics include:
- Understanding Phase 3 clinical trials
- Trial design and what it means for families
- What participation may involve
- Questions from the Angelman syndrome community